A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly ...
Gene editing has moved from theory to bedside with a speed that would have seemed impossible a decade ago. A new wave of ...
Despite emerging clinical successes, current genome editors suffer from off-target effects and can trigger unwanted responses from the immune system, limiting their broader therapeutic applications.
In a 15-patient, Phase 1, first-in-human trial, a one-time CRISPR-Cas9 gene-editing therapy safely reduced LDL cholesterol and triglycerides in people with difficult-to-treat lipid disorders, ...
AI therapeutics company built on causal biology, today announced the publication of research in Nature Communications validating its POSH (Pooled Optical Screening in Human cells) platform. The study ...
In 2025, CRISPR advanced gene editing with safe, effective therapies and AI tools, marking a shift towards real-world ...
Megan Molteni reports on discoveries from the frontiers of genomic medicine, neuroscience, and reproductive tech. She joined STAT in 2021 after covering health and science at WIRED. You can reach ...